| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.80▼ | 1.80▼ | 1.80▼ | 1.80▼ | 1.82▼ |
| MA10 | 1.81▼ | 1.81▼ | 1.81▼ | 1.81▼ | 2.30▼ |
| MA20 | 1.81▼ | 1.81▼ | 1.81▼ | 1.82▼ | 3.41▼ |
| MA50 | 1.83▼ | 1.83▼ | 1.84▼ | 2.46▼ | 7.96▼ |
| MA100 | 1.84▼ | 1.83▼ | 1.83▼ | 3.54▼ | 285.87▼ |
| MA200 | 1.84▼ | 1.96▼ | 2.14▼ | 5.03▼ | 334.94▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.003▼ | -0.002▼ | 0.053▲ | 1.393▲ |
| RSI | 39.972▼ | 39.869▼ | 41.059▼ | 36.264▼ | 31.827▼ |
| STOCH | 8.333▼ | 8.333▼ | 8.333▼ | 21.675 | 13.762▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -82.609▼ | -88.000▼ |
| CCI | -147.786▼ | -147.786▼ | -154.710▼ | -81.177 | -72.915 |
|
Thursday, September 24, 2026 05:05 AM
Detailed price information for Aptevo Therapeutics Inc (APVO-Q) from The Globe and Mail including charting and trades.
|
|
Monday, August 24, 2026 02:02 AM
Aptevo Therapeutics, Inc. (NASDAQ: APVO) is currently focused on the continued clinical progress with mipletamig, a $1.5 million non-dilutive grant to advance APVO451, and the company's recently ...
|
|
Friday, August 14, 2026 04:10 PM
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(5.31) per share which beat the analyst consensus estimate of $(6.16) by 13.8 percent. This is a 96.49 percent increase over losses of $ ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/10/26 | 1.79 | 1.81 | 1.78 | 1.79 | 6,689 |
| 08/10/26 | 1.77 | 1.84 | 1.77 | 1.80 | 26,719 |
| 07/10/26 | 1.76 | 1.85 | 1.76 | 1.84 | 12,106 |
| 06/10/26 | 1.82 | 1.92 | 1.79 | 1.795 | 35,387 |
| 05/10/26 | 1.76 | 1.85 | 1.75 | 1.80 | 28,043 |
| 02/10/26 | 1.80 | 1.80 | 1.76 | 1.76 | 12,268 |
| 01/10/26 | 1.8203 | 1.84 | 1.75 | 1.76 | 25,083 |
| 30/09/26 | 1.84 | 1.90 | 1.81 | 1.82 | 23,825 |
| 29/09/26 | 1.90 | 1.91 | 1.84 | 1.86 | 15,025 |
| 28/09/26 | 1.86 | 1.98 | 1.86 | 1.91 | 46,990 |
|
|
||||
|
|
||||
|
|